Novocuff Raises $26 Million in Oversubscribed Series A Funding to Advance Technology Aimed at Reducing Preterm Births

MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–Novocuff, Inc., a medical device company dedicated to improving pregnancy outcomes and reducing the risk of preterm birth, has successfully closed an oversubscribed $26 million Series A funding round after raising an initial $2 million seed round. AXA IM Alts, through its Global Healthcare Private Equity Strategy, led the round with a $14 million investment, alongside significant participation from Laerdal Million Lives Fund, and continued support from ex